Dicynone 500 mg 20 mg

50.60

Product description

Etamsylate 500 mg tablets

What is Etamsylate and what is it used for?

  • Etamsylate belongs to a group of medicines called antihemorrhagic, antifibrinolytic, and amino acid-lowering drugs.
  • Etamsylate is used in adults and children over 1 year of age to prevent and treat bleeding due to a process that prevents blood clotting called fibrinolysis.

Specific uses include:

  • Heavy menstrual periods in women.

Gastrointestinal bleeding;

  • Bleeding urinary tract disorders after surgery on the prostate gland or urinary tract.
  • After surgery on your ear, nose, or throat.
  • After heart, abdominal, or gynecological surgery.
  • Bleeding after treatment with another drug to break up blood clots.

What you need to know before using Etamsylate:

Do not use Etamsylate:

Tell your doctor if any of the following apply to you before you start using this medicine:

  • You are allergic (hypersensitive) to etamsylate or any of the other ingredients of this medicine
  • You have or have ever had a condition that causes blood clotting.
  • You have a condition called 'consumption coagulation' where the blood throughout your body starts to clot.
  • You have kidney problems.
  • You have a history of convulsions (seizures).

Warnings and Precautions:

You should tell your doctor if:

  • If you have blood in your urine, which may indicate a clot in your upper urinary tract.
  • If you are at risk of blood clots.
  • If you have excessive clotting or bleeding throughout your body (disseminated intravascular coagulation), your doctor may perform a blood test to see if the process that prevents blood clotting (called fibrinolysis) has been activated;
  • If you have convulsions (seizures). Your doctor will use the lowest possible dose to avoid further convulsions after treatment;
  • If you are taking long-term treatment with etamsylate, be careful to monitor your color vision for any possible changes. If necessary, your doctor may discontinue treatment. Regular eye exams are recommended for long-term treatment with etamsylate. If changes in your eyes are noticed, your doctor may consult an ophthalmologist to decide whether to continue treatment.

Other medicines and Etamsylate:

  • Tell your doctor about the medications you are taking, especially if you are taking:
  • Other medications that help blood clotting, called antifibrinolytics.
  • Medicines that prevent blood clotting are called thrombolytic drugs.
  • Oral contraceptives.

How to use Etamsylate:

  • Your doctor will decide the correct dose for you and how long you should take it.

Use in adults:

Treatment of local fibrinolysis:

  • The usual dose is 500-1000 mg three times a day.

Treatment of general fibrinolysis:

  • The usual dose is 1000 mg every 6 to 8 hours or up to 15 mg per kg of body weight.

Use in children:

  • The doctor will decide the appropriate dose for your child and how long he or she should take it.
  • If Etamsylate is given to a child over 1 year old, the dose will depend on the child's body weight.

Use in the elderly:

  • It is not necessary to reduce the dose unless you have kidney problems.
  • Use in patients with kidney problems
  • If you have kidney problems, the dosage may be reduced. Your doctor will decide the appropriate dosage based on a blood test.

Possible side effects:

Stop using the product and seek immediate medical attention if:

  • Swelling of the face, lips, tongue, or throat, which may cause difficulty breathing or swallowing
  • Signs of blood clots

How to store Etamsylate:

  • Keep all medicines out of the reach and sight of children.
  • Do not store above 25°C. Store in the original package. Do not refrigerate or freeze.
  • Do not use this medicine after the expiry date shown on the blister.
  • Do not dispose of medications down the drain or in the trash. Ask your pharmacist what to do with any medications you no longer need. This will help protect the environment.
  • The dosage form and route of administration of Etamsylate should be prescribed according to the therapeutic indication and severity of the disease for each individual patient.


Questions you might have

‌
‌
‌‌
‌
‌
‌‌
‌
‌
‌‌
‌
‌
‌‌
‌
‌
‌‌
‌
‌
‌‌
‌